Impact BioMedical Inc. (IBO) stock
IBONYSEPharmaceutical PreparationsFiscal year ends December 31
$3.06+0.38 (+14.18%)
Close on Oct 19, 2026Market cap $26.14MP/E –Yield –
Impact BioMedical total assets
Total assets on the balance sheet at the end of each period.
Impact BioMedical's total assets was $16.43M at Sep 30, 2026. For fiscal 2025 it was $17.41M, down 14.2% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.41M | -14.2% |
| FY2024 | Dec 31, 2024 | $20.29M | -54.5% |
| FY2023 | Dec 31, 2023 | $44.63M | -4.0% |
| FY2022 | Dec 31, 2022 | $46.50M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $16.43M | -9.8% |
| Q2 FY2026 | Jun 30, 2026 | $16.75M | -12.1% |
| Q1 FY2026 | Mar 31, 2026 | $17.09M | -14.8% |
| Q4 FY2025 | Dec 31, 2025 | $17.41M | -14.2% |
| Q3 FY2025 | Sep 30, 2025 | $18.21M | -61.0% |
| Q2 FY2025 | Jun 30, 2025 | $19.06M | -56.8% |
| Q1 FY2025 | Mar 31, 2025 | $20.05M | -54.8% |
| Q4 FY2024 | Dec 31, 2024 | $20.29M | -54.5% |
| Q3 FY2024 | Sep 30, 2024 | $46.70M | +3.6% |
| Q2 FY2024 | Jun 30, 2024 | $44.12M | -4.1% |
| Q1 FY2024 | Mar 31, 2024 | $44.36M | -4.6% |
| Q4 FY2023 | Dec 31, 2023 | $44.63M | – |
| Q3 FY2023 | Sep 30, 2023 | $45.08M | – |
| Q2 FY2023 | Jun 30, 2023 | $45.99M | – |
| Q4 FY2022 | Dec 31, 2022 | $46.50M | – |
See a number that looks wrong?